ZNF143 inhibits hepatocyte mitophagy and promotes non-alcoholic fatty liver disease by targeting increased lncRNA NEAT1 expression to activate ROCK2 pathway

Background: Nonalcoholic fatty liver disease (NAFLD) is the most common hepatic disorders worldwide. The mitophagy is suggested to be repressed in NAFLD, but the mechanism remains to be elucidated. Methods: NAFLD cell and mouse models were established by treating with free fatty acid (FFA) and feedi...

Full description

Bibliographic Details
Main Authors: Yujie Dong, Minjie Hu, Kewei Tan, Rongjuan Dai
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Epigenetics
Subjects:
Online Access:http://dx.doi.org/10.1080/15592294.2023.2239592
_version_ 1797678734567800832
author Yujie Dong
Minjie Hu
Kewei Tan
Rongjuan Dai
author_facet Yujie Dong
Minjie Hu
Kewei Tan
Rongjuan Dai
author_sort Yujie Dong
collection DOAJ
description Background: Nonalcoholic fatty liver disease (NAFLD) is the most common hepatic disorders worldwide. The mitophagy is suggested to be repressed in NAFLD, but the mechanism remains to be elucidated. Methods: NAFLD cell and mouse models were established by treating with free fatty acid (FFA) and feeding a high fat diet (HFD), respectively. QRT-PCR, Western blotting, or IHC measured the expression of ZNF143, lncRNA NEAT1, ROCK2, and lipid formation/mitophagy-related proteins. Cell viability and mitophagy were evaluated by MTT and immunofluorescence. The chloroform-methanol extraction method measured triglyceride and total cholesterol levels. ELISA detected ALT and AST levels. The interactions among ZNF143, lncRNA NEAT1 and SND1 were analysed by ChIP, dual-luciferase reporter, pull-down, and RIP. The lipid droplets were determined by Oil-red O and HE staining. Results: ZNF143 and lncRNA NEAT1 were upregulated in hepatic cells treated with FFA (p < 0.01 and p < 0.001). Knockdown of ZNF143 or lncRNA NEAT1 inhibited lipid droplets formation, while promoting mitophagy (p < 0.01 and p < 0.001). ZNF143 promoted lncRNA NEAT1 transcriptional expression through binding to its promoter. LncRNA NEAT1 increased ROCK2 mRNA stability by targeting SND1. LncRNA NEAT1 or ROCK2 overexpression reversed the effect of ZNF143 or lncRNA NEAT1 knockdown on hepatic steatosis and mitophagy (p < 0.01 and p < 0.001). ZNF143 or lncRNA NEAT1 knockdown inhibited HFD-induced steatosis and promoted mitophagy in vivo (p < 0.01 and p < 0.001). Conclusion: The upregulation of lncRNA NEAT1 caused by ZNF143 promoted NAFLD through inhibiting mitophagy via activating ROCK2 pathway by targeting SND1, providing potential targets for NAFLD therapy.
first_indexed 2024-03-11T23:04:52Z
format Article
id doaj.art-22cb7b9d79444cb5a42e22dcb4401a15
institution Directory Open Access Journal
issn 1559-2294
1559-2308
language English
last_indexed 2024-03-11T23:04:52Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Epigenetics
spelling doaj.art-22cb7b9d79444cb5a42e22dcb4401a152023-09-21T13:23:14ZengTaylor & Francis GroupEpigenetics1559-22941559-23082023-12-0118110.1080/15592294.2023.22395922239592ZNF143 inhibits hepatocyte mitophagy and promotes non-alcoholic fatty liver disease by targeting increased lncRNA NEAT1 expression to activate ROCK2 pathwayYujie Dong0Minjie Hu1Kewei Tan2Rongjuan Dai3University of South ChinaUniversity of South ChinaDepartment of the Laboratory and Blood TransfusionUniversity of South ChinaBackground: Nonalcoholic fatty liver disease (NAFLD) is the most common hepatic disorders worldwide. The mitophagy is suggested to be repressed in NAFLD, but the mechanism remains to be elucidated. Methods: NAFLD cell and mouse models were established by treating with free fatty acid (FFA) and feeding a high fat diet (HFD), respectively. QRT-PCR, Western blotting, or IHC measured the expression of ZNF143, lncRNA NEAT1, ROCK2, and lipid formation/mitophagy-related proteins. Cell viability and mitophagy were evaluated by MTT and immunofluorescence. The chloroform-methanol extraction method measured triglyceride and total cholesterol levels. ELISA detected ALT and AST levels. The interactions among ZNF143, lncRNA NEAT1 and SND1 were analysed by ChIP, dual-luciferase reporter, pull-down, and RIP. The lipid droplets were determined by Oil-red O and HE staining. Results: ZNF143 and lncRNA NEAT1 were upregulated in hepatic cells treated with FFA (p < 0.01 and p < 0.001). Knockdown of ZNF143 or lncRNA NEAT1 inhibited lipid droplets formation, while promoting mitophagy (p < 0.01 and p < 0.001). ZNF143 promoted lncRNA NEAT1 transcriptional expression through binding to its promoter. LncRNA NEAT1 increased ROCK2 mRNA stability by targeting SND1. LncRNA NEAT1 or ROCK2 overexpression reversed the effect of ZNF143 or lncRNA NEAT1 knockdown on hepatic steatosis and mitophagy (p < 0.01 and p < 0.001). ZNF143 or lncRNA NEAT1 knockdown inhibited HFD-induced steatosis and promoted mitophagy in vivo (p < 0.01 and p < 0.001). Conclusion: The upregulation of lncRNA NEAT1 caused by ZNF143 promoted NAFLD through inhibiting mitophagy via activating ROCK2 pathway by targeting SND1, providing potential targets for NAFLD therapy.http://dx.doi.org/10.1080/15592294.2023.2239592nafldznf143lncrna neat1rock2snd1mitophagy
spellingShingle Yujie Dong
Minjie Hu
Kewei Tan
Rongjuan Dai
ZNF143 inhibits hepatocyte mitophagy and promotes non-alcoholic fatty liver disease by targeting increased lncRNA NEAT1 expression to activate ROCK2 pathway
Epigenetics
nafld
znf143
lncrna neat1
rock2
snd1
mitophagy
title ZNF143 inhibits hepatocyte mitophagy and promotes non-alcoholic fatty liver disease by targeting increased lncRNA NEAT1 expression to activate ROCK2 pathway
title_full ZNF143 inhibits hepatocyte mitophagy and promotes non-alcoholic fatty liver disease by targeting increased lncRNA NEAT1 expression to activate ROCK2 pathway
title_fullStr ZNF143 inhibits hepatocyte mitophagy and promotes non-alcoholic fatty liver disease by targeting increased lncRNA NEAT1 expression to activate ROCK2 pathway
title_full_unstemmed ZNF143 inhibits hepatocyte mitophagy and promotes non-alcoholic fatty liver disease by targeting increased lncRNA NEAT1 expression to activate ROCK2 pathway
title_short ZNF143 inhibits hepatocyte mitophagy and promotes non-alcoholic fatty liver disease by targeting increased lncRNA NEAT1 expression to activate ROCK2 pathway
title_sort znf143 inhibits hepatocyte mitophagy and promotes non alcoholic fatty liver disease by targeting increased lncrna neat1 expression to activate rock2 pathway
topic nafld
znf143
lncrna neat1
rock2
snd1
mitophagy
url http://dx.doi.org/10.1080/15592294.2023.2239592
work_keys_str_mv AT yujiedong znf143inhibitshepatocytemitophagyandpromotesnonalcoholicfattyliverdiseasebytargetingincreasedlncrnaneat1expressiontoactivaterock2pathway
AT minjiehu znf143inhibitshepatocytemitophagyandpromotesnonalcoholicfattyliverdiseasebytargetingincreasedlncrnaneat1expressiontoactivaterock2pathway
AT keweitan znf143inhibitshepatocytemitophagyandpromotesnonalcoholicfattyliverdiseasebytargetingincreasedlncrnaneat1expressiontoactivaterock2pathway
AT rongjuandai znf143inhibitshepatocytemitophagyandpromotesnonalcoholicfattyliverdiseasebytargetingincreasedlncrnaneat1expressiontoactivaterock2pathway